Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Faber

Showing results (31-40 of 199) with videos related to

Pageof 20
Sort By:
The New England Journal of Medicine|July 31, 1997
The management of hypertrophic cardiomyopathyH Seggewiss, U Gleichmann, L Faber
Deutsche Medizinische Wochenschrift (1946)|March 13, 2008
[Surgical treatment of the hypereosinophilic syndrome with cardiac involvement (Löffler's endocarditis)]S Jategaonkar, T Butz, L Faber
Circulation|December 1, 1998
Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: results with respect to intraprocedural myocardial contrast echocardiographyL Faber, H Seggewiss, U Gleichmann
Aspen'S Advisor for Nurse Executives|July 1, 1994
Beepers for families: a creative solutionS Johnson, L Faber, N McNair
Archiv Der Pharmazie Und Berichte Der Deutschen Pharmazeutischen Gesellschaft|March 1, 1971
[Absolute configuration of 2 alkaloids in Cynachum vincetoxicum (L.) Pers]W Wiegrebe, L Faber, T Breyhan
Deutsche Medizinische Wochenschrift (1946)|September 20, 1991
[The provocation of dynamic obstruction of the left ventricular outflow tract in secondary myocardial hypertrophy]L Faber, H W Klempt, M Dumitriu
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 2, 1999
Intraprocedural myocardial contrast echocardiography as a routine procedure in percutaneous transluminal septal myocardial ablation: detection of threatening myocardial necrosis distant from the septal target areaL Faber, H Seggewiss, P Ziemssen, et al.
Annual Review of Pharmacology and Toxicology|January 6, 2022
Central Nervous System Control of Glucose Homeostasis: A Therapeutic Target for Type 2 Diabetes?Zaman Mirzadeh, Chelsea L Faber, Michael W Schwartz
Heart (British Cardiac Society)|March 4, 2000
Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: long term follow up of the first series of 25 patientsL Faber, A Meissner, P Ziemssen, et al.
Deutsche Medizinische Wochenschrift (1946)|May 12, 2001
[One-year follow-up after echocardiographically-guided percutaneous septal ablation in hypertrophic obstructive cardiomyopathy]H Seggewiss, L Faber, P Ziemssen, et al.
Pageof 20

Showing results (31-40 of 199) with videos related to

Sort By:
Pageof 20
The New England Journal of Medicine|July 31, 1997
The management of hypertrophic cardiomyopathyH Seggewiss, U Gleichmann, L Faber
Deutsche Medizinische Wochenschrift (1946)|March 13, 2008
[Surgical treatment of the hypereosinophilic syndrome with cardiac involvement (Löffler's endocarditis)]S Jategaonkar, T Butz, L Faber
Circulation|December 1, 1998
Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: results with respect to intraprocedural myocardial contrast echocardiographyL Faber, H Seggewiss, U Gleichmann
Aspen'S Advisor for Nurse Executives|July 1, 1994
Beepers for families: a creative solutionS Johnson, L Faber, N McNair
Archiv Der Pharmazie Und Berichte Der Deutschen Pharmazeutischen Gesellschaft|March 1, 1971
[Absolute configuration of 2 alkaloids in Cynachum vincetoxicum (L.) Pers]W Wiegrebe, L Faber, T Breyhan
Deutsche Medizinische Wochenschrift (1946)|September 20, 1991
[The provocation of dynamic obstruction of the left ventricular outflow tract in secondary myocardial hypertrophy]L Faber, H W Klempt, M Dumitriu
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 2, 1999
Intraprocedural myocardial contrast echocardiography as a routine procedure in percutaneous transluminal septal myocardial ablation: detection of threatening myocardial necrosis distant from the septal target areaL Faber, H Seggewiss, P Ziemssen, et al.
Annual Review of Pharmacology and Toxicology|January 6, 2022
Central Nervous System Control of Glucose Homeostasis: A Therapeutic Target for Type 2 Diabetes?Zaman Mirzadeh, Chelsea L Faber, Michael W Schwartz
Heart (British Cardiac Society)|March 4, 2000
Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: long term follow up of the first series of 25 patientsL Faber, A Meissner, P Ziemssen, et al.
Deutsche Medizinische Wochenschrift (1946)|May 12, 2001
[One-year follow-up after echocardiographically-guided percutaneous septal ablation in hypertrophic obstructive cardiomyopathy]H Seggewiss, L Faber, P Ziemssen, et al.
Pageof 20